Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

被引：3
|
作者：
Kourie, Hampig Raphael [1 ]
Awada, Gil [2 ]
Awada, Ahmad Hussein [1 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, Brussels, Belgium
[2] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Brussels, Belgium
来源：
FUTURE ONCOLOGY | 2016年 / 12卷 / 04期
关键词：
cancer; checkpoint inhibitors; clinical trial; diagnosis; future; immunotherapies; ipilimumab; nivolumab; pembrolizumab; unknown primary tumor; NIVOLUMAB; ANTI-PD-1; SAFETY;
D O I：
10.2217/fon.15.329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：429 / 431
页数：3
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitors in Melanoma of Unknown Primary
    Ho, F.
    Torphy, R. J.
    Tobin, R. P.
    Borgers, J. S.
    Vorwald, V. M.
    Amato, C. A.
    Van Gulick, R.
    Cogswell, D. T.
    Gonzalez, R.
    Lewis, K. D.
    Medina, T. M.
    Rioth, M. J.
    Gleisner, A. L.
    Robinson, W. A.
    McCarter, M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S105 - S106
  • [2] Immune checkpoint inhibitors in patients with cancers of unknown primary
    Rassy, Elie
    Karam, Elias
    Adeleke, Sola
    Okoli, Somto
    Galante, Joao
    Boussios, Stergios
    Pavlidis, Nicholas
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [3] Exploring the role of immune checkpoint inhibitors in solitary fibrous tumors
    Assi, Tarek
    Moussa, Tania
    Le Cesne, Axel
    IMMUNOTHERAPY, 2025,
  • [4] Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary
    Rassy, Elie
    Boussios, Stergios
    Pavlidis, Nicholas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (09)
  • [5] Role of immune checkpoint inhibitors in bone sarcomas and future aspects
    Mishra, A. N.
    Medhashri, S.
    Mishra, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [6] Thymic tumors and immune checkpoint inhibitors
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1509 - S1515
  • [7] Therapeutic Development of Immune Checkpoint Inhibitors
    Wang, Jilin
    Yang, Teddy
    Xu, Jie
    REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 : 619 - 649
  • [8] Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
    Abboud, Karen
    Umoru, Godsfavour
    Esmail, Abdullah
    Abudayyeh, Ala
    Murakami, Naoka
    Al-Shamsi, Humaid O. O.
    Javle, Milind
    Saharia, Ashish
    Connor, Ashton A. A.
    Kodali, Sudha
    Ghobrial, Rafik M. M.
    Abdelrahim, Maen
    CANCERS, 2023, 15 (05)
  • [9] Fever of unknown origin associated with immune checkpoint inhibitors
    Tong, Xu
    Zhan, Tao
    Dong, Xiaoqin
    Xu, Dong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Immune Checkpoint Inhibitors in Progressive Neuroendocrine Tumors
    Chauhan, Aman
    Anthony, Lowell
    PANCREAS, 2018, 47 (03) : 335 - 335
12345